SEC Form 4 · accession 0001280776-16-000020
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Henry
Officer — VP, Clinical Operations
Period of report
Aug 15, 2016
Accepted (ET)
Aug 17, 2016 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $6.35 | Aug 15, 2016 | A | 3,152 | A | — | Aug 14, 2026 | Common Stock | 3,152 | 3,152 | I |
Explanation of responses
- F1One forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly beginning on July 1, 2016, such that all of the shares of common stock subject to the option are vested by July 1, 2020, subject to the daughter's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")) through each vesting date.
- F2The reporting person disclaims beneficial ownership of the securities indicated, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner thereof for purposes of Section 16 or for any other purpose.